Moreover, we did not observe any associations between miR-486-5p, miR-320e levels and indicators of AD patients including age, gender, Aβ levels (Aβ1-42, Aβ1-40, and Aβ1-42/Aβ1-40), and Tau levels (total Tau and p-Tau) (Figure S3B, C). This evidence concerns the gene MAPT and Alzheimer disease.